Melbourne, Australia – 29 April 2020: Adherium Limited (ASX:ADR), a leader in digital inhaled device adherence, remote monitoring and data management solutions, has signed a heads of terms sales agreement with Monaghan Medical Corporation, a US subsidiary of Trudell Medical Limited, a parent company of a multinational group of leading companies in the medical device and healthcare service sectors, including Trudell Medical International. Monaghan is a leader in the development and manufacture of innovative, high quality, patient-oriented aerosol drug delivery devices and respiratory management solutions in the United States.